ATI Physical Therapy EBITDA Margin 2020-2024 | ATIP

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ATI Physical Therapy (ATIP) over the last 10 years. The current EBITDA margin for ATI Physical Therapy as of March 31, 2024 is .
ATI Physical Therapy EBITDA Margin Historical Data
2024-03-31 $0.71B $0.07B 10.11%
2023-12-31 $0.70B $0.07B 9.46%
2023-09-30 $0.68B $0.06B 8.41%
2023-06-30 $0.66B $0.05B 6.99%
2023-03-31 $0.65B $0.05B 7.24%
2022-12-31 $0.64B $0.04B 5.97%
2022-09-30 $0.63B $0.03B 5.24%
2022-06-30 $0.63B $0.04B 5.70%
2022-03-31 $0.63B $0.06B 8.85%
2021-12-31 $0.63B $0.07B 10.99%
2021-06-30 $0.46B $0.07B 15.15%
2021-03-31 $0.41B $0.03B 6.16%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.021B $0.699B
ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00